Trusted Resources: People & Places
Healthcare providers, researchers, and advocates
Saint Luke’s Amyloid Program
Saint Luke's Hospital of Kansas City4401 Wornall Road
Kansas City, Missouri, United States
Phone Web
The Saint Luke’s Amyloid Program, comprised of a multidisciplinary team of physicians, is dedicated to diagnosing and treating patients with all forms of amyloidosis. This comprehensive team includes cardiology, hematology, nephrology, and neurology physicians. Members of the team have extensively published research and been involved in clinical trials, and are committed to treatment of amyloidosis in their patients.
Saint Luke’s Health System includes 16 hospitals and campuses across the Kansas City region, home care and hospice, behavioral health care, dozens of physician practices, a life care senior living community, and more.
Saint Luke’s Hospital offers a variety of diagnostic tests that can lead to amyloidosis diagnosis. These tests include:
• Specialized blood and urine tests
• Markers of heart, kidney, and liver dysfunction
• Advanced echocardiography with longitudinal strain analysis
• Cardiac magnetic resonance imaging (MRI)
• Technetium pyrophosphate nuclear scintigraphyThe team includes healthcare professionals in the following areas:
• Biopsy of the bone marrow, heart, kidneys, or soft tissue in of the abdomen
The team includes healthcare professional in the following area:
Cardiology:
Brett W. Sperry, MD
Related Content
-
Patrick Hagen, MDPatrick Hagen is an Assistant Professo...
-
Rahma Warsame, MDDr. Rahma Warsame is an Associate Profes...
-
AL Amyloidosis FAQsWhat is AL amyloidosis? The term ‘amy...
-
New Concepts in the Treatment and Diagnosis of AmyloidosisThe most common form of systemic amyloid...
-
Impact of Genetic Testing in Transthyretin (ATTR) Cardiac AmyloidosisPurpose of Review The review's main foc...
-
ISA 2020 | Post-Renal Transplantation Hematological Response Assessment: AL Amyloidosishttps://www.youtube.com/watch?v=PS40iQUJ...
-
Hereditary Amyloidosis CanadaThe Hereditary Amyloidosis Canada (HAC) ...
To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences.
More information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.